首页> 美国卫生研究院文献>ACS AuthorChoice >Design and Evaluation of aRobust PID Controller for a Fully ImplantableArtificial Pancreas
【2h】

Design and Evaluation of aRobust PID Controller for a Fully ImplantableArtificial Pancreas

机译:设计与评估坚固的PID控制器可完全植入人工胰腺

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Treatment of type 1 diabetes mellitus could be greatly improved by applying a closed-loop control strategy to insulin delivery, also known as an artificial pancreas (AP). In this work, we outline the design of a fully implantable AP using intraperitoneal (IP) insulin delivery and glucose sensing. The design process utilizes the rapid glucose sensing and insulin action offered by the IP space to tune a PID controller with insulin feedback to provide safe and effective insulin delivery. The controller was tuned to meet robust performance and stability specifications. An anti-reset windup strategy was introduced to prevent dangerous undershoot toward hypoglycemia after a large meal disturbance. The final controller design achieved 78% of time within the tight glycemic range of 80–140 mg/dL, with no time spent in hypoglycemia. The next step is to test this controller design in an animal model to evaluate the in vivo performance.
机译:通过将闭环控制策略应用于胰岛素输送(也称为人工胰腺(AP)),可以大大改善1型糖尿病的治疗。在这项工作中,我们概述了使用腹膜内(IP)胰岛素输送和葡萄糖感应的完全可植入AP的设计。设计过程利用IP空间提供的快速葡萄糖感应和胰岛素作用来调节具有胰岛素反馈的PID控制器,以提供安全有效的胰岛素输送。该控制器经过调整,可以满足鲁棒的性能和稳定性规范。引入了一种防重置缠绕策略,以防止大餐后出现低血糖的危险下冲。最终的控制器设计在80-140 mg / dL的严格血糖范围内达到了78%的时间,而没有时间花费在低血糖症上。下一步是在动物模型中测试此控制器设计,以评估体内性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号